rewirebio.iobenchmarks
Source

Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia

Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML · Peer-reviewed

DOI: 10.1016/j.jmoldx.2026.01.007

What this source contributed

Records in this release that cite this source. A record can cite several sources.

Results

Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.

Model or configurationMetricValueDatasetEvaluation
FUSILLI on nanopore cDNA reads (Lin et al. 2026)F1 (per-sample dominant B-ALL fusion, high-depth cohort)0.86 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FUSILLI on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
FUSILLI on nanopore cDNA reads (Lin et al. 2026)Precision (per-sample dominant B-ALL fusion, high-depth cohort)0.92 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FUSILLI on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
FUSILLI on nanopore cDNA reads (Lin et al. 2026)Recall (per-sample dominant B-ALL fusion, high-depth cohort)0.81 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FUSILLI on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
FUSILLI on nanopore cDNA reads (Lin et al. 2026)Specificity (per-sample dominant B-ALL fusion, high-depth cohort)0.92 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FUSILLI on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
FUSILLI on nanopore cDNA reads (Lin et al. 2026)F1 (per-sample dominant B-ALL fusion, low-depth cohort)0.42 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FUSILLI on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
FUSILLI on nanopore cDNA reads (Lin et al. 2026)Precision (per-sample dominant B-ALL fusion, low-depth cohort)0.92 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FUSILLI on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
FUSILLI on nanopore cDNA reads (Lin et al. 2026)Recall (per-sample dominant B-ALL fusion, low-depth cohort)0.27 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FUSILLI on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
FUSILLI on nanopore cDNA reads (Lin et al. 2026)Specificity (per-sample dominant B-ALL fusion, low-depth cohort)0.95 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FUSILLI on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
FusionSeeker on nanopore cDNA reads (Lin et al. 2026)F1 (per-sample dominant B-ALL fusion, high-depth cohort)0.76 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FusionSeeker on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
FusionSeeker on nanopore cDNA reads (Lin et al. 2026)Precision (per-sample dominant B-ALL fusion, high-depth cohort)0.94 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FusionSeeker on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
FusionSeeker on nanopore cDNA reads (Lin et al. 2026)Recall (per-sample dominant B-ALL fusion, high-depth cohort)0.63 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FusionSeeker on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
FusionSeeker on nanopore cDNA reads (Lin et al. 2026)Specificity (per-sample dominant B-ALL fusion, high-depth cohort)0.96 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FusionSeeker on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
FusionSeeker on nanopore cDNA reads (Lin et al. 2026)F1 (per-sample dominant B-ALL fusion, low-depth cohort)0.16 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FusionSeeker on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
FusionSeeker on nanopore cDNA reads (Lin et al. 2026)Precision (per-sample dominant B-ALL fusion, low-depth cohort)1.00 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FusionSeeker on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
FusionSeeker on nanopore cDNA reads (Lin et al. 2026)Recall (per-sample dominant B-ALL fusion, low-depth cohort)0.09 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FusionSeeker on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
FusionSeeker on nanopore cDNA reads (Lin et al. 2026)Specificity (per-sample dominant B-ALL fusion, low-depth cohort)1.00 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)FusionSeeker on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
JAFFAL on nanopore cDNA reads (Lin et al. 2026)F1 (per-sample dominant B-ALL fusion, high-depth cohort)0.78 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)JAFFAL on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
JAFFAL on nanopore cDNA reads (Lin et al. 2026)Precision (per-sample dominant B-ALL fusion, high-depth cohort)0.79 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)JAFFAL on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
JAFFAL on nanopore cDNA reads (Lin et al. 2026)Recall (per-sample dominant B-ALL fusion, high-depth cohort)0.76 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)JAFFAL on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
JAFFAL on nanopore cDNA reads (Lin et al. 2026)Specificity (per-sample dominant B-ALL fusion, high-depth cohort)0.81 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)JAFFAL on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
JAFFAL on nanopore cDNA reads (Lin et al. 2026)F1 (per-sample dominant B-ALL fusion, low-depth cohort)0.36 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)JAFFAL on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
JAFFAL on nanopore cDNA reads (Lin et al. 2026)Precision (per-sample dominant B-ALL fusion, low-depth cohort)0.90 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)JAFFAL on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
JAFFAL on nanopore cDNA reads (Lin et al. 2026)Recall (per-sample dominant B-ALL fusion, low-depth cohort)0.23 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)JAFFAL on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
JAFFAL on nanopore cDNA reads (Lin et al. 2026)Specificity (per-sample dominant B-ALL fusion, low-depth cohort)0.95 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)JAFFAL on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
LongGF on nanopore cDNA reads (Lin et al. 2026)F1 (per-sample dominant B-ALL fusion, high-depth cohort)0.81 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)LongGF on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
LongGF on nanopore cDNA reads (Lin et al. 2026)Precision (per-sample dominant B-ALL fusion, high-depth cohort)0.95 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)LongGF on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
LongGF on nanopore cDNA reads (Lin et al. 2026)Recall (per-sample dominant B-ALL fusion, high-depth cohort)0.70 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)LongGF on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
LongGF on nanopore cDNA reads (Lin et al. 2026)Specificity (per-sample dominant B-ALL fusion, high-depth cohort)0.96 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)LongGF on paediatric B-ALL nanopore WTS, high-depth (Lin et al. 2026)
LongGF on nanopore cDNA reads (Lin et al. 2026)F1 (per-sample dominant B-ALL fusion, low-depth cohort)0.27 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)LongGF on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
LongGF on nanopore cDNA reads (Lin et al. 2026)Precision (per-sample dominant B-ALL fusion, low-depth cohort)0.93 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)LongGF on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
LongGF on nanopore cDNA reads (Lin et al. 2026)Recall (per-sample dominant B-ALL fusion, low-depth cohort)0.16 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)LongGF on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)
LongGF on nanopore cDNA reads (Lin et al. 2026)Specificity (per-sample dominant B-ALL fusion, low-depth cohort)0.97 fractionPaediatric B-ALL nanopore PCR-cDNA whole-transcriptome sequencing (UNC, St Jude, ECOG-ACRIN)LongGF on paediatric B-ALL nanopore WTS, low-depth (Lin et al. 2026)

Claims

Statements this source supports, each with where in the source it was checked.

  • computational_cost: long-read fusion callers (Lin et al. 2026): Computational cost Table 5 (high-depth cohort, averages): FusionSeeker 50 min 26 s real time and 30.01 GB RAM; JAFFAL 96 min 7 s and 45.31 GB, including its own alignment; LongGF 10 min 22 s and 8.88 GB; FUSILLI 1 min 45 s and 2.13 GB; minimap2 alignment, needed by all but JAFFAL, 157 min 55 s and 31.75 GB. (Table 5 and footnote)
  • Evidence summary: tumour RNA fusion detection workflows: Summary Four comparisons join the Seraseq reference and paediatric NCH cohort evidence; values cannot be pooled across studies. Tamura et al. 2026 ran 12 short-read callers on haematologic cancer cell lines; one, Genomon, comes from a co-author's group. On 61 driver fusions in conventional RNA-seq of 170 cell lines, Arriba detected all 61 (TPR 1), FusionCatcher 0.98, STAR-Fusion 0.93, InFusion 0.43 and STARChip 0.41. On 24 driver fusions in targeted RNA-seq of 26 cell lines, Arriba again reached 1 and STAR-Fusion 0.92, InFusion 0.17 and STARChip 0. A driver fusion entered these truth sets only if at least four callers, including the one scored, found it and it had literature or RT-PCR support, so fusions that most callers miss are under-represented and these values may overstate sensitivity. Against a consensus of the other callers, the number of single-caller calls, a measure of review burden, ranged on conventional RNA-seq from 327 for TrinityFusion-D and 1,061 for STAR-Fusion (PPV 0.39) to 9,567 for Arriba (PPV 0.08), 22,445 for FusionCatcher and 695,295 for Pizzly. On nanopore long reads from 51 paediatric B-ALL samples (Lin et al. 2026), scored on the dominant fusion per sample, JAFFAL reached sensitivity 0.76, LongGF 0.70 and FusionSeeker 0.63, with precision 0.79 to 0.95; the authors' own FUSILLI reached 0.81. At about one eighth of the depth, sensitivity was 0.09 to 0.27. In an independent long-read benchmark (Dorney et al. 2026 preprint), no caller exceeded F1 0.35 on 400 simulated fusions at 100 Gb and 95% read identity: CTAT-LR-Fusion 0.35 (recall 0.28, precision 0.46), JAFFAL 0.29, Genion 0.20, FusionSeeker 0.14, GFSeeker 0.07 and LongGF 0.04. On all ONT PCR-cDNA reads of the MCF7 cell line, CTAT-LR-Fusion's calls matched 20 of 53 previously reported fusions, with 51 other calls; JAFFAL matched 19 with 38 other calls and FusionSeeker 11 with 359. The other calls mix real fusions missing from the literature list and false calls. On the Huh7 cell line, pooling six long-read callers per long-read platform and three short-read callers for Illumina, PacBio Kinnex recovered 20 of 34 previously reported fusions, ONT PCR-cDNA 17 and Illumina 15. Against karyotyping, FISH and RT-PCR in 101 adult and paediatric acute leukaemia patients (Kim et al. 2026), an Arriba workflow with manual review detected 40 of 48 conventionally detected fusions (sensitivity 83.3%) and called fusions in 21.4% of 56 conventionally negative results; these count against specificity, although the authors describe several as well-known recurrent fusions and confirmed one by RT-PCR and Sanger sequencing. These are cell lines, simulations and leukaemia samples: no linked comparison covers solid-tumour specimens, FFPE tissue or novel-fusion discovery, only Kim et al. score against orthogonal clinical assays, none reports interval estimates, and none establishes clinical performance. (amp-oncology-rna-20261007-source-pmc8642973: Seraseq and NCH results; rna-fusion-20261009-source-tamura2026-supplementary: Supplementary Tables 3 and 5; rna-fusion-20261009-source-tamura2026: Methods and Author contributions; rna-fusion-20261009-source-lin2026: Tables 3 and 6, Results; rna-fusion-longread-20261011-source-dorney2026: see claims.csv of its batch; rna-fusion-longread-20261011-source-dorney2026-repository: see claims.csv of its batch; rna-fusion-leukaemia-20261011-source-kim2025: see claims.csv of its batch)
  • Evidence summary: tumour RNA fusion detection workflows: attributes.value: Claimed value Four comparisons join the Seraseq reference and paediatric NCH cohort evidence; values cannot be pooled across studies. Tamura et al. 2026 ran 12 short-read callers on haematologic cancer cell lines; one, Genomon, comes from a co-author's group. On 61 driver fusions in conventional RNA-seq of 170 cell lines, Arriba detected all 61 (TPR 1), FusionCatcher 0.98, STAR-Fusion 0.93, InFusion 0.43 and STARChip 0.41. On 24 driver fusions in targeted RNA-seq of 26 cell lines, Arriba again reached 1 and STAR-Fusion 0.92, InFusion 0.17 and STARChip 0. A driver fusion entered these truth sets only if at least four callers, including the one scored, found it and it had literature or RT-PCR support, so fusions that most callers miss are under-represented and these values may overstate sensitivity. Against a consensus of the other callers, the number of single-caller calls, a measure of review burden, ranged on conventional RNA-seq from 327 for TrinityFusion-D and 1,061 for STAR-Fusion (PPV 0.39) to 9,567 for Arriba (PPV 0.08), 22,445 for FusionCatcher and 695,295 for Pizzly. On nanopore long reads from 51 paediatric B-ALL samples (Lin et al. 2026), scored on the dominant fusion per sample, JAFFAL reached sensitivity 0.76, LongGF 0.70 and FusionSeeker 0.63, with precision 0.79 to 0.95; the authors' own FUSILLI reached 0.81. At about one eighth of the depth, sensitivity was 0.09 to 0.27. In an independent long-read benchmark (Dorney et al. 2026 preprint), no caller exceeded F1 0.35 on 400 simulated fusions at 100 Gb and 95% read identity: CTAT-LR-Fusion 0.35 (recall 0.28, precision 0.46), JAFFAL 0.29, Genion 0.20, FusionSeeker 0.14, GFSeeker 0.07 and LongGF 0.04. On all ONT PCR-cDNA reads of the MCF7 cell line, CTAT-LR-Fusion's calls matched 20 of 53 previously reported fusions, with 51 other calls; JAFFAL matched 19 with 38 other calls and FusionSeeker 11 with 359. The other calls mix real fusions missing from the literature list and false calls. On the Huh7 cell line, pooling six long-read callers per long-read platform and three short-read callers for Illumina, PacBio Kinnex recovered 20 of 34 previously reported fusions, ONT PCR-cDNA 17 and Illumina 15. Against karyotyping, FISH and RT-PCR in 101 adult and paediatric acute leukaemia patients (Kim et al. 2026), an Arriba workflow with manual review detected 40 of 48 conventionally detected fusions (sensitivity 83.3%) and called fusions in 21.4% of 56 conventionally negative results; these count against specificity, although the authors describe several as well-known recurrent fusions and confirmed one by RT-PCR and Sanger sequencing. These are cell lines, simulations and leukaemia samples: no linked comparison covers solid-tumour specimens, FFPE tissue or novel-fusion discovery, only Kim et al. score against orthogonal clinical assays, none reports interval estimates, and none establishes clinical performance. (Crossref record for 10.3343/alm.2025.0300 (volume 46, issue 3, pages 257-269, print 2026-05-01); Lin et al. 2026 dataset records (mean 1.4 M and 11.2 M reads))
  • FUSILLI: description: Description Long-read fusion caller that keeps reads spanning two genes from a B-ALL gene list and fusions on a B-ALL fusion list, with distance, overlap, breakpoint and two-read filters; developed by the authors of the comparison that evaluated it. (Record description; cited Lin et al. 2026)
  • FusionSeeker: description: Description Long-read fusion caller that clusters candidate fusions from BAM alignments and filters them by supporting reads. (Record description; cited Lin et al. 2026)
  • JAFFA: description: Description Fusion caller using alignment to a transcriptomic reference: JAFFA-direct for short reads (BLAT, Bowtie2 and BLAST+) and JAFFAL for long reads, which filters candidates by alignment to the genome. (Record description; cited Tamura et al. 2026; Lin et al. 2026)
  • LongGF: description: Description Long-read fusion caller that compares reads mapped to a reference against a GTF and filters supporting reads. (Record description; cited Lin et al. 2026)
  • Relevance of Paediatric B-ALL long-read fusion calling, high-depth (Lin et al. 2026) to "Select a tumour RNA fusion-detection workflow": Assessed by Paediatric B-ALL nanopore WTS, high-depth cohort, dominant-fusion classification (Lin et al. 2026 Table 3) (rna-fusion-20261009-source-lin2026: Table 3; Materials and Methods 'Fusion Performance Evaluations'; Materials and Methods 'Samples', 'FUSILLI' and 'B-ALL Gene Fusion Master'; Abstract; Discussion)
  • Relevance of Paediatric B-ALL long-read fusion calling, low-depth (Lin et al. 2026) to "Select a tumour RNA fusion-detection workflow": Assessed by Paediatric B-ALL nanopore WTS, low-depth cohort, dominant-fusion classification (Lin et al. 2026 Table 6) (rna-fusion-20261009-source-lin2026: Table 6; Materials and Methods 'Fusion Performance Evaluations'; Materials and Methods 'Samples', 'FUSILLI' and 'B-ALL Gene Fusion Master'; Abstract; Discussion)

Models, benchmarks and other records

Methods (4)

Configurations (4)

Protocols (2)

Datasets (1)

Evaluations (8)

Use cases (1)

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

17 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance
Artifact SHA-256
8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6
Source metadata
Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia

Original source ↗

No field-specific location recorded

Version: Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
Retrieved: 2026-10-09T20:38:17Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_sha256

Source artifact SHA-256: 8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Artifact url
https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13197905/fullTextXML
Source metadata
Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia

Original source ↗

No field-specific location recorded

Version: Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
Retrieved: 2026-10-09T20:38:17Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_url

Source artifact SHA-256: 8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Doi
10.1016/j.jmoldx.2026.01.007
Source metadata
Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia

Original source ↗

No field-specific location recorded

Version: Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
Retrieved: 2026-10-09T20:38:17Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.doi

Source artifact SHA-256: 8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Licence
CC-BY-NC-4.0
Source metadata
Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia

Original source ↗

No field-specific location recorded

Version: Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
Retrieved: 2026-10-09T20:38:17Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.licence

Source artifact SHA-256: 8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Media type
application/xml
Source metadata
Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia

Original source ↗

No field-specific location recorded

Version: Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
Retrieved: 2026-10-09T20:38:17Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.media_type

Source artifact SHA-256: 8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Publication status
peer_reviewed
Source metadata
Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia

Original source ↗

No field-specific location recorded

Version: Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
Retrieved: 2026-10-09T20:38:17Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.publication_status

Source artifact SHA-256: 8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Retrieved at
2026-10-09T20:38:17Z
Source metadata
Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia

Original source ↗

No field-specific location recorded

Version: Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
Retrieved: 2026-10-09T20:38:17Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.retrieved_at

Source artifact SHA-256: 8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Url
https://doi.org/10.1016/j.jmoldx.2026.01.007
Source metadata
Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia

Original source ↗

No field-specific location recorded

Version: Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
Retrieved: 2026-10-09T20:38:17Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.url

Source artifact SHA-256: 8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Version
Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
Source metadata
Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia

Original source ↗

No field-specific location recorded

Version: Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
Retrieved: 2026-10-09T20:38:17Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
Primary source retrieved and hashed for the tumour RNA fusion use-case pass.
Source metadata
Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia

Original source ↗

No field-specific location recorded

Version: Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
Retrieved: 2026-10-09T20:38:17Z

catalogued

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

Primary source retrieved and hashed for the tumour RNA fusion use-case pass.

Release history

No supporting source is linked yet.

Read original source

Download this release (gzip)
Technical metadata and extraction receipts

Stable ID: rna-fusion-20261009-source-lin2026

areas
rna-transcriptomes
contexts
clinical_research
url
https://doi.org/10.1016/j.jmoldx.2026.01.007
artifact url
https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13197905/fullTextXML
version
Journal of Molecular Diagnostics 28(5):406, published 2026-02-10; PMC13197905 full-text XML
retrieved at
2026-10-09T20:38:17Z
artifact sha256
8cc3b4bca5e2fe9b068a1e891366854d974f3df3102425959e600b9ea19f87b6
doi
10.1016/j.jmoldx.2026.01.007
publication status
peer_reviewed
licence
CC-BY-NC-4.0
media type
application/xml
Related records

    Suggest a correction